R
Robert B. Cameron
Researcher at University of California, Los Angeles
Publications - 98
Citations - 3091
Robert B. Cameron is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Mesothelioma & Lung cancer. The author has an hindex of 26, co-authored 92 publications receiving 2890 citations. Previous affiliations of Robert B. Cameron include Cameron International & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Prediction of lung cancer using volatile biomarkers in breath.
Michael Phillips,Nasser K. Altorki,John H.M. Austin,Robert B. Cameron,Renee N. Cataneo,Joel Greenberg,Robert Kloss,Roger A. Maxfield,Muhammad I. Munawar,Harvey I. Pass,Asif Rashid,William N. Rom,Peter Schmitt +12 more
TL;DR: A two-minute breath test predicted lung cancer with accuracy comparable to screening CT of chest, and Alterations in breath VOCs in lung cancer were consistent with a non-linear pathophysiologic process, such as an off-on switch controlling high-risk cytochrome p450 activity.
Journal ArticleDOI
Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer
Mariam Dohadwala,Seok-Chul Yang,Jie Luo,Sherven Sharma,Raj K. Batra,Min Huang,Ying Lin,Lee Goodglick,Kostyantyn Krysan,Michael C. Fishbein,Longsheng Hong,Chi Lai,Robert B. Cameron,Robert M. Gemmill,Harry A. Drabkin,Steven M. Dubinett +15 more
TL;DR: It is reported that COX-2-dependent pathways contribute to the modulation of E-cadherin expression in NSCLC and that blocking PGE(2) production or activity may contribute to both prevention and treatment of NSCLCs.
Journal ArticleDOI
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features.
TL;DR: Bronchioloalveolar lung carcinoma is a unique type of lung cancer with distinguishing pathologic, biologic, epidemiologic, demographic, and perhaps etiologic features.
Journal ArticleDOI
Detection of lung cancer using weighted digital analysis of breath biomarkers
Michael Phillips,Nasser K. Altorki,John H.M. Austin,Robert B. Cameron,Renee N. Cataneo,Robert Kloss,Roger A. Maxfield,Muhammad I. Munawar,Harvey I. Pass,Asif Rashid,William N. Rom,Peter Schmitt,James Wai +12 more
TL;DR: A test employing WDA of breath VOCs predicted lung cancer with accuracy similar to chest computed tomography, and the algorithm identified dependencies that were not apparent with traditional linear methods.
Journal ArticleDOI
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
Cecelia S Yap,Johannes Czernin,Michael C. Fishbein,Robert B. Cameron,Christiaan Schiepers,Michael E. Phelps,Wolfgang Weber +6 more
TL;DR: Compared to FDG-PET, detection of primary and metastatic NSCLC by FLT-PET is limited by the relatively low FLT uptake of the tumor tissue and the correlation between PET uptake intensity and tumor cell proliferation suggests that future studies should evaluate the use of FLT -PET for monitoring treatment with cytostatic anticancer drugs.